article-10-16-2020

NRI is excited to share these clinically relevant results for the efficacy and safety of Exenatide plus Dapagliflozin for patients with uncontrolled type 2 diabetes taking Metformin. We are proud to focus on diseases that affect our community and see great results such as these!

https://care.diabetesjournals.org/content/43/10/2528.long

 

/ Uncategorized
  • Next Post
  • Previous Post
SIGN UP NOW

Click here to participate in a study

NRI CLINICS ARE CURRENTLY OPEN!
X